论文部分内容阅读
目的分析2006—2008年南京地区22家医院医保甲类中成药的应用状况。方法对南京地区22家医院医保甲类中成药的用药品种、用药金额和用药频度等信息按年度进行统计分析。结果3年中甲类中成药实际使用品种数平均为87种,占医保目录的63.8%,用药金额占全部中成药用药金额的百分比平均为16.7%,并且呈逐年下降趋势。甲类中成药各大类用药金额排序几年保持相对稳定,其中心血管系统用药和其他类药物的用药金额的构成比较高,且增长幅度较大。用药金额前4位的是生脉、参麦、血栓通和复方丹参。用药频度排名显示,复方丹参、柴胡、麝香保心丸和银黄是临床选用频率较高的品种。用药金额最高的剂型是注射剂,而用药频度最高的剂型是胶囊剂。结论南京地区22家医院医保甲类中成药实际使用的品种数偏低,用药金额占中成药总金额的百分比较低,且逐年下降,剂型的使用较为合理,建议医保甲类中成药目录应适当调整并增加品种。
Objective To analyze the status of the use of proprietary Chinese medicines for Class A medical insurance in 22 hospitals in Nanjing from 2006 to 2008. Methods The statistical analysis was conducted on the information on the types, dosages and frequency of medications of Chinese Medicinal Chinese medicines in 22 medical hospitals in Nanjing. Results The average number of actual use of proprietary Chinese proprietary Chinese medicines in category A in the three years was 87, accounting for 63.8% of the medical insurance list. The average percentage of the amount of medication used in all the Chinese patent medicines was 16.7%, and it showed a declining trend year by year. The rankings of the amount of medicines used in Chinese medicines for Category A of Chinese medicines remained relatively stable for several years. The composition of their medications for the central vascular system and other types of medicines was relatively high, and the growth rate was relatively large. The top 4 in the amount of medication are Shengmai, Shenmai, Xuetongtong and Compound Salvia miltiorrhiza. The frequency of medication shows that Compound Danshen, Bupleurum, Huoxiang Baoxin Pills and Yinhuang are higher clinically selected varieties. The dosage form with the highest dosage is injection, and the dosage form with the highest dosage is a capsule. Conclusion The actual use of Chinese proprietary Chinese medicine in 22 hospitals in 22 medical districts in Nanjing was low, the percentage of medication used was a relatively low percentage of the total amount of Chinese patent medicines, and it decreased year by year. The use of dosage forms was reasonable. It is recommended that the list of Chinese medicines for category A should be appropriate. Adjust and add varieties.